Compare Medtronic PLC (MDT) vs PayPal Holdings, Inc. (PYPL) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

PayPal (PYPL) trades at $56.78, up 0.38% with strong technical momentum as the stock approaches resistance near $57-$59 following a $53 billion takeover bid from Stripe and Advent International. The company shows solid fundamentals with 2025 revenue of $33.17B, net income of $5.23B (15% margin), and attractive valuation metrics including a P/E of 10.6 and P/S of 1.6. Recent earnings beat expectations in Q1 2026 with EPS of $1.34 versus $1.27 expected.

The acquisition offer at $60.50 per share provides near-term upside potential, though the board considers it undervalued. Key risks include regulatory hurdles for the deal and competitive pressures in digital payments. Analyst sentiment is mixed with 36% buy ratings but a consensus price target of $50.80 below current levels, suggesting cautious optimism amid takeover speculation.